Delivery Order SPE2DR25D3012-SPE2DR26F4J8J
Award Date 3/30/26
Potential Completion Date 4/20/26
Potential Value $26K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $25,665.63 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for Ibrance 125 mg tablets (7-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of...
- The Defense Logistics Agency issued a $25,665.63 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for supply of Ibrance 125 mg tablets (7s). This delivery order is issued under the DLA Troop Support Medical indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2026. The contract provides pharmaceutical and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for Ibrance 125 mg tablets (7-count). Place of performance is Conshohocken, PA. Ultimate completion date is April 20, 2026. The order is firm fixed price with no set-aside and represents a call against the parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, which supplies pharmaceutical products and medical...
- <p>The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for Ibrance 125 mg tablets (7-count package).</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, a global pharmaceutical supply vehicle. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of April 20, 2026.</p>
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 10, 2026, and is priced as firm fixed price with no set-aside. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for Ibrance 125 mg tablets (7-count packages) with a ceiling value of $8,555.21. Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of March 16, 2026. This delivery order was issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which provides...
- The Defense Logistics Agency issued a $25,684.23 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for Ibrance 75 mg tablets (7-count packaging), with a completion date of March 31, 2026. The order is issued under the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is...
- The Defense Logistics Agency issued a $85,614.10 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for Ibrance 75 mg tablets (7-count). The order is issued under Amerisourcebergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price...
- The Defense Logistics Agency issued an $8,555.21 delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Ibrance 125 mg tablets (7-count). The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate...
- The Defense Logistics Agency issued a $8,559.84 delivery order to AmerisourceBergen Drug Corp on March 18, 2026, for supply of Ibrance 100 mg tablets (7-count). The order is issued under the DLA Troop Support Medical IDC, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, enabling supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4J8JDelivery Order
The Defense Logistics Agency issued a $25,665.63 delivery order to Amerisourcebergen Drug Corp on March 30, 2026, for supply of Ibrance 125 mg tablets (7 count) under firm fixed pricing. Place of performance is Conshohocken, PA. The order has an ultimate completion date of April 20, 2026. This delivery order was issued under the parent IDC held by Cencora, Inc. (Amerisourcebergen's parent entity) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999 through December 2031 that delivers brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally. No set-aside was used.
Generated 6/28/26, 10:00 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.7k | 3/29/26 |